CAD 0.03
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -316.56 Thousand CAD | 66.38% |
2022 | -941.52 Thousand CAD | -1.61% |
2021 | -926.63 Thousand CAD | -57.92% |
2020 | -586.77 Thousand CAD | -1193.28% |
2019 | -45.37 Thousand CAD | 80.74% |
2018 | -235.56 Thousand CAD | 22.01% |
2017 | -302.05 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -205.88 Thousand CAD | -38.95% |
2024 Q2 | -206.04 Thousand CAD | -0.08% |
2023 Q2 | 154.18 Thousand CAD | 406.98% |
2023 Q4 | -148.17 Thousand CAD | 9.24% |
2023 FY | -316.56 Thousand CAD | 66.38% |
2023 Q3 | -163.26 Thousand CAD | -205.89% |
2023 Q1 | -50.22 Thousand CAD | 90.62% |
2022 Q2 | -244.05 Thousand CAD | -32.32% |
2022 Q4 | -535.69 Thousand CAD | -188.47% |
2022 Q3 | -185.7 Thousand CAD | 23.91% |
2022 Q1 | -184.44 Thousand CAD | 79.47% |
2022 FY | -941.52 Thousand CAD | -1.61% |
2021 Q4 | -898.37 Thousand CAD | -7919.46% |
2021 FY | -926.63 Thousand CAD | -57.92% |
2021 Q2 | -16.85 Thousand CAD | 75.75% |
2021 Q1 | -69.5 Thousand CAD | 90.21% |
2021 Q3 | 11.48 Thousand CAD | 168.16% |
2020 Q3 | -15.15 Thousand CAD | -165.72% |
2020 Q2 | 23.06 Thousand CAD | 62.5% |
2020 Q1 | 14.19 Thousand CAD | 172.36% |
2020 FY | -586.77 Thousand CAD | -1193.28% |
2020 Q4 | -709.58 Thousand CAD | -4581.89% |
2019 Q3 | 14.99 Thousand CAD | 164.93% |
2019 Q4 | -19.61 Thousand CAD | -230.76% |
2019 FY | -45.37 Thousand CAD | 80.74% |
2019 Q2 | -23.09 Thousand CAD | -32.88% |
2019 Q1 | -17.38 Thousand CAD | 48.65% |
2018 Q2 | 10.65 Thousand CAD | 106.09% |
2018 FY | -235.56 Thousand CAD | 22.01% |
2018 Q4 | -33.85 Thousand CAD | 13.41% |
2018 Q3 | -39.09 Thousand CAD | -466.88% |
2018 Q1 | -174.96 Thousand CAD | 0.0% |
2017 FY | -302.05 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
AI/ML Innovations Inc. | -1.66 Million CAD | 80.986% |
Diagnamed Holdings Corp. | -1.17 Million CAD | 73.12% |
Pangenomic Health Inc. | -2.71 Million CAD | 88.326% |
Treatment.Com International Inc. | -2.32 Million CAD | 86.396% |
Unidoc Health Corp. | -2.2 Million CAD | 85.615% |